These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26032517)

  • 1. hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2).
    Li Q; Sun H; Shu Y; Zou X; Zhao Y; Ge C
    Cell Prolif; 2015 Aug; 48(4):436-42. PubMed ID: 26032517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth.
    Zhang J; Liu H; Pan H; Yang Y; Huang G; Yang Y; Zhou WP; Pan ZY
    Biochem Biophys Res Commun; 2014 Sep; 452(3):575-80. PubMed ID: 25181338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.
    Wang C; Liu X; Chen Z; Huang H; Jin Y; Kolokythas A; Wang A; Dai Y; Wong DT; Zhou X
    Mol Carcinog; 2013 Mar; 52(3):229-36. PubMed ID: 22161744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
    Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
    Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
    Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
    Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
    Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
    Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
    Huang SD; Yuan Y; Zhuang CW; Li BL; Gong DJ; Wang SG; Zeng ZY; Cheng HZ
    Mol Cancer; 2012 Aug; 11():51. PubMed ID: 22867052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.
    Li Z; Wang Y; Qiu J; Li Q; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Yang J; Cheng J
    Oncotarget; 2013 Dec; 4(12):2532-49. PubMed ID: 24345883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60.
    Peng L; Ling H; Yuan Z; Fang B; Bloom G; Fukasawa K; Koomen J; Chen J; Lane WS; Seto E
    Mol Cell Biol; 2012 Jul; 32(14):2823-36. PubMed ID: 22586264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 12. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
    Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
    PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
    Zhou X; Ren Y; Kong L; Cai G; Sun S; Song W; Wang Y; Jin R; Qi L; Mei M; Wang X; Kang C; Li M; Zhang L
    Oncotarget; 2015 Oct; 6(32):33720-32. PubMed ID: 26378043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
    Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
    Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.
    Zheng L; Li N; Guo F; Jian XC; Jiang CH; Yin P; Min AJ; Huang L
    Mol Med Rep; 2015 Mar; 11(3):2255-61. PubMed ID: 25378227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma.
    Chen J; Tang S; Zheng Q; Li J; Jiang H; Lu H; Liao G; Li K; Liang Y
    Exp Cell Res; 2024 Mar; 436(1):113957. PubMed ID: 38309675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
    Yang G; Li Z; Chen L
    Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
    Yu Q; Du Y; Wang S; Zheng X
    J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma.
    Ding X; Zhang N; Cai Y; Li S; Zheng C; Jin Y; Yu T; Wang A; Zhou X
    Mol Oncol; 2012 Feb; 6(1):73-80. PubMed ID: 22153618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.